Zepbound and tirzepatide share an ingredient but not a product. What differs between the brand and compounded versions, according to FDA.
Partly. Zepbound and Mounjaro both contain tirzepatide, and both are made by Eli Lilly. A compounded tirzepatide product has the same active ingredient name, but it is a different product: a pharmacy makes it, it is not FDA-approved, and FDA does not verify its safety, effectiveness or quality before it is marketed. So when people ask whether tirzepatide is the same as Zepbound, the honest answer is that the ingredient matches and the product does not. This guide explains the difference in plain terms.
This article is general information. It is not medical advice or a dose recommendation. Your prescribing provider sets your dose.
Is tirzepatide the same as Zepbound?
Tirzepatide is the active ingredient. Zepbound is a brand name for a medicine that contains it. The Zepbound label describes tirzepatide as a GIP receptor and GLP-1 receptor agonist, which means it acts on the GIP and GLP-1 hormone receptors. Eli Lilly and Company makes it.
Think of it like the difference between an ingredient and a branded recipe. The ingredient has a name. The brand is one specific, regulated product that contains it, with a fixed formulation and an FDA-approved label.
Zepbound vs Mounjaro: what is the difference?
Both brands come from the same company and contain tirzepatide. The difference is what each one is approved to treat, according to the labels on Zepbound and Mounjaro on DailyMed.
| Brand | Maker | Active ingredient | Approved use on the label |
|---|---|---|---|
| Zepbound | Eli Lilly and Company | Tirzepatide | Weight reduction and long-term weight maintenance in adults with obesity, or with overweight and a weight-related condition. Also moderate to severe obstructive sleep apnea in adults with obesity. |
| Mounjaro | Eli Lilly and Company | Tirzepatide | An addition to diet and exercise to improve blood sugar control in adults with type 2 diabetes. |
Source: the Zepbound and Mounjaro prescribing information on DailyMed (both updated August 2026 when we checked). Labels change, so always read the current version.
The Zepbound label lists single-dose pens and single-dose vials. Your provider decides which medicine, if any, is appropriate for you.
What is compounded tirzepatide?
Compounding is when a pharmacy prepares a medicine for an individual patient from a prescription, instead of dispensing a manufactured, FDA-approved product. FDA is direct about the status of these products: on its compounding questions and answers page it says compounded drugs are not FDA-approved, and that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.
That is a statement about review, not a verdict on every product. It means the finished product has not been through FDA approval, so quality depends heavily on the pharmacy that prepares it and the provider who prescribes it.
Brand vs compounded tirzepatide: what actually differs?
| Zepbound or Mounjaro | Compounded tirzepatide | |
|---|---|---|
| Who makes it | Eli Lilly and Company | A pharmacy preparing it for an individual prescription |
| FDA approval | FDA-approved for the uses on its label | Not FDA-approved |
| FDA check of safety, effectiveness and quality before sale | Reviewed when FDA approved the brand product | FDA does not verify these before marketing |
| Prescribing information | FDA-approved label for the product | No FDA-approved label for the compounded product itself |
| How it is supplied | Set by the manufacturer (pens and vials for Zepbound) | Set by the pharmacy, so it can differ |
Because supply formats and strengths can differ between products, never copy a dose or a unit count from one product to another. Your prescribing provider sets your dose.
Why does compounded tirzepatide exist?
FDA’s page on compounder policies explains what changed once the national tirzepatide shortage ended. It says it determined the tirzepatide injection shortage was resolved on 19 December 2024, and it set end dates for the shortage-related compounding allowance: 18 February 2025 for state-licensed pharmacies and physicians, and 19 March 2025 for outsourcing facilities.
FDA also says it intends to treat a compounded drug as “essentially a copy” of a commercially available drug in certain cases. This is a regulatory area that keeps changing, and the details are for pharmacies and prescribers to apply. It is a fair question for your own provider: how does the product I am being prescribed fit current FDA policy?
How do you check what you are getting?
FDA’s advice for patients is to get a prescription from your doctor and fill it at a state-licensed pharmacy. A few questions help, whichever product you are offered:
- Is this a brand product (Zepbound or Mounjaro) or a compounded one?
- Which pharmacy prepares or dispenses it, and is it state-licensed?
- How is it supplied, as a pen or a vial, and what do the label and instructions say?
- Who do I contact if I have a problem or a question after I start?
Our guide on how to check before you order online walks through the same kind of checks, and our comparison of TrumpRx and specially compounded GLP-1 options covers how the routes differ. If you are on a compounded product, this guide to the starting dose of compounded tirzepatide explains how the clinic’s published schedule works.
Frequently asked questions
Is tirzepatide the same as Zepbound?
Tirzepatide is the active ingredient in Zepbound. Zepbound is the FDA-approved brand-name product made by Eli Lilly. A compounded tirzepatide product shares the ingredient name but is a different product.
Is Mounjaro the same as Zepbound?
Both contain tirzepatide and both are made by Eli Lilly. Mounjaro is labeled for type 2 diabetes. Zepbound is labeled for weight management and for obstructive sleep apnea in adults with obesity.
Is compounded tirzepatide FDA-approved?
No. FDA says compounded drugs are not FDA-approved and that it does not verify their safety, effectiveness or quality before they are marketed.
Does Zepbound come in vials?
Yes. The Zepbound label lists a single-dose pen and a single-dose vial. Your provider and pharmacy tell you which one applies to your prescription.
Can I switch between Zepbound and a compounded product?
That is a decision for your prescribing provider. Products can be supplied differently, so do not switch or convert a dose on your own.
Do I need a prescription for tirzepatide?
Yes. FDA advises patients to get a prescription from their doctor and fill it at a state-licensed pharmacy.
Sources
- Zepbound prescribing information (DailyMed)
- Mounjaro prescribing information (DailyMed)
- FDA: Compounding and the FDA, questions and answers
- FDA: concerns with unapproved GLP-1 drugs used for weight loss
- FDA: policies for compounders as national GLP-1 supply stabilizes
More from this guide series
Next step
To see whether a prescribed GLP-1 is right for you, start the free intake form. The clinic will contact you to schedule an appointment, and a licensed provider reviews your health before anything is prescribed. You can also see the current plans on the tirzepatide pricing and programs page.